Published in Am J Respir Cell Mol Biol on April 01, 1997
Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J Virol (1999) 0.98
Abnormalities in host defense associated with HIV infection. Clin Chest Med (2013) 0.81
Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem (1999) 2.81
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol (1998) 2.14
Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun (1998) 1.60
Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber Lung Dis (1997) 1.58
Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol (1997) 1.50
Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis (1998) 1.34
Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis (1994) 1.27
Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol (2000) 1.20
Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med (1993) 1.19
T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis (1996) 1.16
Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res (1989) 1.16
Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis (1997) 1.13
Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis (1987) 1.13
Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem (1999) 1.07
Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol (1996) 1.02
Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS (1996) 1.01
Serum keratan sulfate. Quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum (1991) 1.00
Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis (2000) 1.00
Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis (1995) 1.00
Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med (2001) 0.99
Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trial. HIV Clin Trials (2011) 0.93
Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis. J Immunol (1995) 0.91
Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells. J Clin Invest (1990) 0.88
Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell Mol Biol (1993) 0.87
Restricted expression of anti-type II collagen antibody isotypes in mice suppressed for collagen-induced arthritis. Ann Rheum Dis (1986) 0.85
Preliminary characterization of accessory cells in the nonadherent fraction of human blood mononuclear cells. Cell Immunol (1986) 0.83
Accessory function of human mononuclear phagocytes for lymphocyte responses to the superantigen staphylococcal enterotoxin B. Cell Immunol (1992) 0.82
Identification of a type V collagen-degrading enzyme from human sputum. Am Rev Respir Dis (1983) 0.80
Dysregulation of beta-chemokines in the lungs of HIV-1-infected patients. J Acquir Immune Defic Syndr (2001) 0.80
Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell Immunol (2001) 0.78
Lymphocytic alveolitis in a crematorium worker. Chest (1994) 0.78
Iron metabolism by smokers' alveolar macrophages: protective or problematic in the lung? J Lab Clin Med (1988) 0.76
Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J Gerontol (1993) 0.76
Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity. J Lab Clin Med (1994) 0.75
Interleukin-1 production by blood monocytes and bronchoalveolar cells in sarcoidosis. Ann N Y Acad Sci (1986) 0.75
Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. Am J Kidney Dis (1993) 0.75
[Neonatal herpetic encephalitis. Current concepts concerning a case]. Rev Invest Clin (1996) 0.75
[Low doses of AZT: is it really a good option?]. Rev Invest Clin (1993) 0.75
Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial. Clin Infect Dis (1999) 0.75